Liquid chromatography-tandem mass spectrometry assay for therapeutic drug monitoring of the tyrosine kinase inhibitor, midostaurin, in plasma from patients with advanced systemic mastocytosis

We developed and validated quantitative bioanalytical liquid chromatography-tandem mass spectrometry assay for the protein kinase inhibitor, midostaurin. Plasma samples were pre-treated using a protein precipitation with methanol containing midostaurin-d5 as an internal standard. After centrifugation, 5μL of the supernatant was injected into the chromatographic system. The system consisted of a 3.5μm particle bonded octadecyl silica column, with gradient elution using a mixture of 0.1% (v/v) formic acid in acetonitrile and 10mM ammonium formate in water with 0.1% formic acid. The analyte was quantified using the selected reaction-monitoring mode of a triple quadrupole mass spectrometer equipped with a heated electrospray interface. The assay was validated in a 75-2500ng/mL calibration range. For quality control, within-day and between-day precisions were 1.2-2.8%, and 1.2-6.9%, respectively. The β-expectation tolerance limit (accuracy) met the limits of acceptance ±15% (±20% for the LLQ). The drug was sufficiently stable under all relevant analytical conditions. The assay has successfully been used to assess drug levels for therapeutic drug monitoring in patients presenting advanced systemic mastocytosis and treated with the promising midostaurin.

Benzotriazoles and benzothiazoles in human urine from several countries: a perspective on occurrence, biotransformation, and human exposure

Benzotriazole (BTR) and benzothiazole (BTH) derivatives are high-production-volume chemicals that are mainly used as corrosion inhibitors, and are widely distributed in the environment. BTR derivatives are found in plastics, dishwasher detergents, dry cleaning equipment, and de-icing/anti-icing fluids. BTH derivatives are found in rubber materials, herbicides, slimicides, algicides, fungicides, photosensitizers, azo dyes, drugs, de-icing/anti-icing fluids, and food flavors. However, exposure of humans to BTRs and BTHs is still not known. In this study, six BTRs (1H-benzotriazole, 1-hydroxy-benzotriazole, 4- and 5-hydroxy-benzotriazole [mixture of two isomers], tolyltriazole, xylyltriazole [or 5,6-dimethyl-1H-benzotriazole], and 5-chloro-benzotriazole) and six BTHs (benzothiazole, 2-morpholin-4-yl-benzothiazole, 2-hydroxy-benzothiazole, 2-methylthio-benzothiazole, 2-amino-benzothiazole, and 2-thiocyanomethylthio-benzothiazole) were determined in human urine collected from general populations in seven countries (the U.S., Greece, Vietnam, Korea, Japan, China, and India). The median urinary concentration of the sum of five BTRs (Σ5BTRs; 4- and 5-hydroxy-benzotriazole were not included) ranged from 0.2 (Korea) to 2.8 (India)ng/mL among the countries studied, with the highest concentration of 24.5ng/mL found in a sample from China. Xylyltriazole was found more frequently in urine from all five Asian countries than in urine from the U.S. and Greece. The median concentration of the sum of the six BTHs (Σ6BTHs) ranged from 3.6 (U.S.) to 10.9 (Japan)ng/mL among the countries studied, with a maximum detection rate of 100% in urine samples from Vietnam; BTH was the predominant derivative, accounting for, on average, 43% of the Σ6BTH concentration. Based on the concentrations and detection rates of several BTR and BTH derivatives in urine, possible metabolic transformation pathways of these compounds were presented and human exposure doses calculated. The estimated daily intake doses of BTRs and BTHs were on the order of a few to few tens of micrograms per day.